Results 11 to 20 of about 207,765 (264)

Current advances in Hodgkin’s lymphoma

Chronic Diseases and Translational Medicine, 2019
Hodgkin’s lymphoma is a highly treatable malignancy. It has high cure rates yet there are many patients who relapse or are refractory to treatment. Traditionally, treatment has been with conventional chemotherapy; however, the development of brentuximab ...
Joseph Vadakara, Benjamin Andrick
doaj   +2 more sources

Hodgkin’s Lymphoma [PDF]

, 2020
Hodgkin’s lymphoma occurs frequently in younger age. Fertility preservation is an important issue as survival rates are very high and some of the treatments are highly gonadotoxic.
von Wolff, Michael, Carolin Bürkle, Karolin Behringer, Behringer, Karolin, Michael von Wolff, Bürkle, Carolin   +5 more
core   +2 more sources

The impact of molecular alterations and the immune microenvironment on the natural history of Follicular Lymphoma including transformation to Diffuse Large B cell Lymphoma [PDF]

, 2009
PhDThe natural history of follicular lymphoma is heterogeneous with numerous relapses and remissions over many years. A substantial number of patients suffer an aggressive disease course with death due to disease within 5 years of diagnosis.
Lee, Abigail Mary
core   +4 more sources

Sexual functioning in male survivors of lymphoma: a systematic review [PDF]

, 2011
Introduction: the lymphomas [Hodgkin’s Lymphoma (HL) and Non-Hodgkin’s Lymphoma (NHL)] are among the most common cancers affecting men under 45 years. Survival rates are now excellent, but treatment is associated with a number of side effects including ...
Pacey, Allan, Arden-Close, Emily, Pacey, A., Eiser, C., Pacey, Allan; id_orcid, Emily Arden-Close, Arden-Close, E., Christine Eiser, Eiser, Christine, Allan Pacey   +9 more
core   +1 more source

Nodular lymphocyte predominant hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma : endpoints of a spectrum of one disease? [PDF]

, 2013
In contrast to the commonly indolent clinical behavior of nodular lymphocyte predominant Hodgkin lymphoma (NLPHL), T cell/histiocyte rich large B cell lymphoma (THRLBCL) is frequently diagnosed in advanced clinical stages and has a poor prognosis ...
Benjamin Rengstl, Sebastian Newrzela, Randy Gascoyne, Xavier Sagaert (482298), Xavier Sagaert, Hartmann, Sylvia, Martin-Leo Hansmann, Claudia Döring, Küppers, Ralf, Chris de Wolf-Peeters, Fabio Facchetti, Ralf Küppers, Fabio Facchetti (376587), Sylvia Hartmann, Rengstl, Benjamin, Hansmann, Martin-Leo, Christian Steidl, Sagaert, Xavier, Martin-Leo Hansmann (260067), Tousseyn, Thomas, Christian Steidl (482300), Ralf Küppers (260072), Thomas Tousseyn (482297), Chris de Wolf-Peeters (482299), Steidl, Christian, Claudia Döring (474984), Ponzoni, Maurilio, Randy Gascoyne (482301), Jakobus, Christina, Wolf-Peeters, Chris de, Benjamin Rengstl (482295), Sebastian Newrzela (482296), Gascoyne, Randy, Maurilio Ponzoni (126480), Döring, Claudia, Thomas Tousseyn, Christina Jakobus (482294), Christina Jakobus, Facchetti, Fabio, Sylvia Hartmann (260069), Newrzela, Sebastian, Maurilio Ponzoni   +41 more
core   +2 more sources

Long-term follow-up of patients treated with radiotherapy alone for early-stage histologically aggressive non-Hodgkin's lymphoma [PDF]

, 2004
Historically localised aggressive non-Hodgkin's lymphoma (NHL) has been treated with involved field radiotherapy (RT), chemotherapy, or a combination of both modalities. The current weight of evidence supports a preference for combined modality treatment
P Hoskin, P Smith, Linch, D, J Spicer, B Hancock, Spicer, J, Hoskin, P, R Pettengell, Hancock, B, K Maclennan, Spicer, J; id_orcid, Smith, P, Pettengell, R, D Linch, Maclennan, K   +14 more
core   +1 more source

Pulmonary manifestations of lymphoma: A pictorial essay

Lung India, 2020
Lymphomatous involvement of the lungs manifests in an infinite number of ways. Often there is a considerable overlap of the patterns of manifestations which comes as a diagnostic challenge to the radiologist.
Bhoomi Angirish, Parang Sanghavi, Bhavin Jankharia   +2 more
doaj   +1 more source

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma [PDF]

, 2004
We report the outcomes after reduced-intensity conditioning allogeneic stem cell transplantation (RIT) for non-Hodgkin lymphoma (NHL) in 88 patients (low-grade NHL [LG-NHL], n = 41; high-grade NHL [HG-NHL], n = 37; mantle cell lymphoma [MCL], n = 10 ...
Mahendra, P, Smith, GM, Cook, G., Hatton, C., Tighe, J., Morris, E., Goldstone, A, Peggs, K., Cook, G, Mahendra, Premini, Hunter, A., Mackinnon, S, Milligan, D., Smith, G.M., Goldstone, A., Chopra, R, Hunter, A, Linch, D., Parker, A, Linch, D, Morris, E, Hunter, A.H., Milligan, D, Thomson, K, Parker, A., Peggs, K, Chopra, R., Thomson, K., Craddock, C., Hatton, C, Mackinnon, S., Milligan, Donald, Mahendra, P., Schey, S., Craddock, Charles; id_orcid, Craddock, C, Schey, S, Tighe, J   +37 more
core   +1 more source

Inutility of IMP3 Marker in Differentiating Hodgkin Lymphoma from Large Cell Lymphoma

Basic & Clinical Cancer Research, 2020
Background: Hodgkin’s lymphoma is one of the most commonly diagnosed lymphomas in Western society. Today Reed-Sternberg cells are identified by positive staining of several biomarkers.
Ali Zare Mehrjerdi, Mahdie Ahmadi
doaj   +1 more source

Spontaneous regression of primary progressive Hodgkin’s lymphoma in a pediatric patient: A case report and review of literature

Hematology/Oncology and Stem Cell Therapy, 2013
Spontaneous regression of malignancies is a very rare phenomenon. Our research of existing literature yielded only 16 cases of Hodgkin's lymphoma which regressed spontaneously.
Karthik Udupa, Arun Philip, Rejiv Rajendranath, Tenali Sagar, Urmila Majhi   +4 more
doaj   +1 more source